Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.78EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.231EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.49EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.67EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.190EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.120EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AM.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AA.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.249EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AA.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.505EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.74EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
B.1.406EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.115EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.29EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AA.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.133EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.466EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.489EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.363EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.95EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.531EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.45EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.200EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.299EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.55EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.149EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.300EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.179EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.25EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.125EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
G.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.438EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.35EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.178EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.208EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.197EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.491EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EV.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.1.8 (Gamma)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.39.3 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BQ.1.8.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.75.3 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.35EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CY.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used